AG˹ٷ

STOCK TITAN

[Form 4] Blend Labs, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Winnie Ling, Head of Legal and People at Blend Labs, reported a sale of 4,000 shares of Class A common stock on 08/07/2025. The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. The filing reports a weighted average sale price of $3.6192 per share, with sale prices ranging from $3.61 to $3.645 per share and notes that a breakdown of shares sold at each price is available on request.

Following the reported transaction Ling directly beneficially owns 372,018 shares. The disposal reduced her pre-sale direct holding by roughly 1.06%, consistent with a modest, preplanned disposition under an established trading plan rather than an ad hoc sale.

Winnie Ling, Head of Legal and People di Blend Labs, ha comunicato la vendita di 4,000 azioni ordinarie di Classe A il 08/07/2025. L'operazione è stata effettuata nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato dalla dichiarante il 14 marzo 2025. La segnalazione indica un prezzo medio ponderato di vendita di $3.6192 per azione, con prezzi compresi tra $3.61 e $3.645 per azione; è disponibile su richiesta il dettaglio delle azioni vendute a ciascun prezzo.

Al termine della transazione Ling detiene direttamente beneficiariamente 372,018 azioni. La cessione ha ridotto la sua partecipazione diretta pre-vendita di circa il 1.06%, coerente con una disposizione modesta e preprogrammata nell'ambito di un piano stabilito anziché con una vendita occasionale.

Winnie Ling, Head of Legal and People en Blend Labs, informó la venta de 4,000 acciones ordinarias Clase A el 08/07/2025. La operación se ejecutó bajo un plan de negociación conforme a la Regla 10b5-1 adoptado por la persona informante el 14 de marzo de 2025. La presentación comunica un precio medio ponderado de venta de $3.6192 por acción, con precios de venta que oscilaron entre $3.61 y $3.645 por acción; está disponible a petición el desglose de cuántas acciones se vendieron a cada precio.

Tras la transacción, Ling posee de forma directa y beneficiaria 372,018 acciones. La enajenación redujo su participación directa previa en aproximadamente un 1.06%, lo que concuerda con una disposición modesta y planificada dentro de un plan establecido y no con una venta puntual.

Winnie Ling 씨는 Blend Labs� Head of Legal and People로서 2025-08-07� 클래� A 보통� 4,000주를 매도했다� 보고했습니다. � 매각은 보고� 본인� 2025� 3� 14�� 채택� Rule 10b5-1 거래계획� 따라 실행되었습니�. 제출서에� 주당 가중평� 매도가격이 $3.6192이며, 거래 가� 범위� 주당 $3.61에서 $3.645까지였�, � 가격대별로 매도� 주식 수의 상세 내역은 요청 � 제공된다� 기재되어 있습니다.

해당 거래 이후 Ling 씨는 직접적으� 수혜적으� 372,018주를 보유하고 있습니다. 이번 처분으로 매도 � 직접 보유지분이 � 1.06% 감소했으�, 이는 일회� 매도가 아니� 확립� 거래계획� 따른 소규� 사전 계획 매각� 일치합니�.

Winnie Ling, Head of Legal and People chez Blend Labs, a déclaré la vente de 4,000 actions ordinaires de classe A le 08/07/2025. La cession a été exécutée dans le cadre d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 14 mars 2025. Le dépôt indique un prix de vente moyen pondéré de $3.6192 par action, avec des prix de vente allant de $3.61 à $3.645 par action ; le détail du nombre d'actions vendues à chaque prix est disponible sur demande.

À la suite de la transaction rapportée, Ling détient directement à titre bénéficiaire 372,018 actions. La cession a réduit sa participation directe avant la vente d'environ 1.06%, conforme à une disposition modeste et préplanifiée dans le cadre d'un plan établi plutôt qu'à une vente ponctuelle.

Winnie Ling, Head of Legal and People bei Blend Labs, meldete den Verkauf von 4,000 Class-A-Stammaktien am 08/07/2025. Der Verkauf erfolgte im Rahmen eines Rule 10b5-1-Handelsplans, den die meldende Person am 14. März 2025 angenommen hatte. Die Meldung gibt einen gewogenen Durchschnittsverkaufspreis von $3.6192 je Aktie an, mit Verkaufspreisen zwischen $3.61 und $3.645 je Aktie; eine Aufschlüsselung der an den einzelnen Preisen verkauften Aktien ist auf Anfrage erhältlich.

Nach der gemeldeten Transaktion besitzt Ling unmittelbar begünstigt 372,018 Aktien. Die Veräußerung verringerte ihre direkte Bestandsposition vor dem Verkauf um rund 1.06%, was mit einer moderaten, vorab geplanten Veräußerung im Rahmen eines etablierten Handelsplans und nicht mit einem ad‑hoc‑Verkauf übereinstimmt.

Positive
  • Transaction was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating a preplanned disposition and supporting regulatory compliance
  • Reporting person retains a substantial direct holding of 372,018 Class A shares after the sale
Negative
  • None.

Insights

TL;DR: Small, preplanned insider sale under a 10b5-1 plan; modest size relative to reported holdings.

The Form 4 discloses a 4,000-share sale at a weighted average price of $3.6192, executed under a Rule 10b5-1 plan adopted March 14, 2025. Post-transaction direct ownership is 372,018 shares, implying the sale reduced pre-sale holdings by about 1.06%. From a financial-significance perspective, this is a routine, small-scale liquidity event that is unlikely to materially affect the company’s capitalization or signal a change in operating outlook based solely on the disclosed facts.

TL;DR: Transaction follows a documented 10b5-1 plan, which supports disclosure and compliance practices.

The report specifically states the sale was made pursuant to a Rule 10b5-1 trading plan, including the plan adoption date and a weighted average price range. That transparency is consistent with good insider-trading governance because it identifies the sale as preplanned. The filing also offers to provide the per-price breakdown on request, which aids regulatory and shareholder review. No other governance events or departures are disclosed in the document.

Winnie Ling, Head of Legal and People di Blend Labs, ha comunicato la vendita di 4,000 azioni ordinarie di Classe A il 08/07/2025. L'operazione è stata effettuata nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato dalla dichiarante il 14 marzo 2025. La segnalazione indica un prezzo medio ponderato di vendita di $3.6192 per azione, con prezzi compresi tra $3.61 e $3.645 per azione; è disponibile su richiesta il dettaglio delle azioni vendute a ciascun prezzo.

Al termine della transazione Ling detiene direttamente beneficiariamente 372,018 azioni. La cessione ha ridotto la sua partecipazione diretta pre-vendita di circa il 1.06%, coerente con una disposizione modesta e preprogrammata nell'ambito di un piano stabilito anziché con una vendita occasionale.

Winnie Ling, Head of Legal and People en Blend Labs, informó la venta de 4,000 acciones ordinarias Clase A el 08/07/2025. La operación se ejecutó bajo un plan de negociación conforme a la Regla 10b5-1 adoptado por la persona informante el 14 de marzo de 2025. La presentación comunica un precio medio ponderado de venta de $3.6192 por acción, con precios de venta que oscilaron entre $3.61 y $3.645 por acción; está disponible a petición el desglose de cuántas acciones se vendieron a cada precio.

Tras la transacción, Ling posee de forma directa y beneficiaria 372,018 acciones. La enajenación redujo su participación directa previa en aproximadamente un 1.06%, lo que concuerda con una disposición modesta y planificada dentro de un plan establecido y no con una venta puntual.

Winnie Ling 씨는 Blend Labs� Head of Legal and People로서 2025-08-07� 클래� A 보통� 4,000주를 매도했다� 보고했습니다. � 매각은 보고� 본인� 2025� 3� 14�� 채택� Rule 10b5-1 거래계획� 따라 실행되었습니�. 제출서에� 주당 가중평� 매도가격이 $3.6192이며, 거래 가� 범위� 주당 $3.61에서 $3.645까지였�, � 가격대별로 매도� 주식 수의 상세 내역은 요청 � 제공된다� 기재되어 있습니다.

해당 거래 이후 Ling 씨는 직접적으� 수혜적으� 372,018주를 보유하고 있습니다. 이번 처분으로 매도 � 직접 보유지분이 � 1.06% 감소했으�, 이는 일회� 매도가 아니� 확립� 거래계획� 따른 소규� 사전 계획 매각� 일치합니�.

Winnie Ling, Head of Legal and People chez Blend Labs, a déclaré la vente de 4,000 actions ordinaires de classe A le 08/07/2025. La cession a été exécutée dans le cadre d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 14 mars 2025. Le dépôt indique un prix de vente moyen pondéré de $3.6192 par action, avec des prix de vente allant de $3.61 à $3.645 par action ; le détail du nombre d'actions vendues à chaque prix est disponible sur demande.

À la suite de la transaction rapportée, Ling détient directement à titre bénéficiaire 372,018 actions. La cession a réduit sa participation directe avant la vente d'environ 1.06%, conforme à une disposition modeste et préplanifiée dans le cadre d'un plan établi plutôt qu'à une vente ponctuelle.

Winnie Ling, Head of Legal and People bei Blend Labs, meldete den Verkauf von 4,000 Class-A-Stammaktien am 08/07/2025. Der Verkauf erfolgte im Rahmen eines Rule 10b5-1-Handelsplans, den die meldende Person am 14. März 2025 angenommen hatte. Die Meldung gibt einen gewogenen Durchschnittsverkaufspreis von $3.6192 je Aktie an, mit Verkaufspreisen zwischen $3.61 und $3.645 je Aktie; eine Aufschlüsselung der an den einzelnen Preisen verkauften Aktien ist auf Anfrage erhältlich.

Nach der gemeldeten Transaktion besitzt Ling unmittelbar begünstigt 372,018 Aktien. Die Veräußerung verringerte ihre direkte Bestandsposition vor dem Verkauf um rund 1.06%, was mit einer moderaten, vorab geplanten Veräußerung im Rahmen eines etablierten Handelsplans und nicht mit einem ad‑hoc‑Verkauf übereinstimmt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ling Winnie

(Last) (First) (Middle)
7250 REDWOOD BLVD., SUITE 300

(Street)
NOVATO CA 94945

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
HEAD OF LEGAL AND PEOPLE
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/07/2025 S(1) 4,000 D $3.6192(2) 372,018 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
2. This sale price represents the weighted average sale price of the shares sold ranging from $3.61 to $3.645 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
/s/ Winnie Ling 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Blend Labs (BLND) insider file report?

The Form 4 reports that Winnie Ling sold 4,000 Class A shares under a Rule 10b5-1 plan at a weighted average price of $3.6192 per share.

How many BLND shares does the reporting person hold after the sale?

After the reported transaction the reporting person directly beneficially owns 372,018 Class A shares.

Was the sale at BLND unusual or preplanned?

The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating it was preplanned.

What was the sale price range disclosed in the BLND Form 4?

The filing discloses sale prices ranged from $3.61 to $3.645 per share and reports a weighted average price of $3.6192.

Can I get a breakdown of how many shares were sold at each price?

Yes. The filing states that upon request the reporting person will provide full information regarding the number of shares sold at each separate price within the disclosed range.
Blend Labs Inc

NYSE:BLND

BLND Rankings

BLND Latest News

BLND Latest SEC Filings

BLND Stock Data

731.29M
245.18M
4.18%
65.01%
3.17%
Software - Application
Services-computer Programming, Data Processing, Etc.
United States
NOVATO